指南与共识消化道肿瘤与早癌消化内镜

亚太胃肠病学会(APAGE)与亚太消化内镜学会(APSDE)关于使用无创生物标志物诊断结直肠肿瘤的联合临床实践指南

Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia.
指南 / 共识 · Gut · 2023-04-05

该指南由亚太胃肠病学会与亚太消化内镜学会联合制定,基于对678篇出版物的系统综述和16名临床医生参与的两阶段德尔菲共识流程,形成32条基于证据和专家意见的推荐,涵盖粪便免疫化学检测、粪便肿瘤或微生物标志物及血液肿瘤标志物用于结直肠癌和腺瘤检测的适应证、患者选择及优缺点。

要点

  • 指南为APAGE与APSDE联合官方声明,针对无创生物标志物诊断结直肠癌及癌前病变。
  • 基于678篇文献系统综述和16名临床医生两阶段德尔菲共识,形成32条推荐。
  • 推荐涵盖粪便免疫化学检测、粪便肿瘤或微生物标志物及血液肿瘤标志物的应用。

核心结论

  • 该联合指南提供最新指导,协助全球临床医生利用无创生物标志物进行结直肠癌筛查,对亚太地区临床医生尤为重要。

研究设计与样本

  • 制定机构为亚太胃肠病学会(APAGE)与亚太消化内镜学会(APSDE),方法为系统综述678篇出版物及16名临床医生参与的两阶段德尔菲共识流程。

主要发现

  • 系统综述678篇出版物,德尔菲共识涉及16名临床医生,形成32条基于证据和专家意见的推荐。
  • 指南提供了每种筛查工具在适应证、患者选择及优缺点方面的最新综合指导。

关键数值与推荐

  • 推荐涵盖粪便免疫化学检测、粪便肿瘤或微生物标志物及血液肿瘤标志物用于结直肠癌和腺瘤检测。
  • 共形成32条基于证据和专家意见的推荐。

临床怎么用

  • 原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Screening for colorectal cancer (CRC) is effective in reducing CRC related mortality. Current screening methods include endoscopy based and biomarker based approaches. This guideline is a joint official statement of the Asian Pacific Association of Gastroenterology (APAGE) and the Asian Pacific Society of Digestive Endoscopy (APSDE), developed in response to the increasing use of, and accumulating supportive evidence for the role of, non-invasive biomarkers for the diagnosis of CRC and its precursor lesions. A systematic review of 678 publications and a two stage Delphi consensus process involving 16 clinicians in various disciplines was undertaken to develop 32 evidence based and expert opinion based recommendations for the use of faecal immunochemical tests, faecal based tumour biomarkers or microbial biomarkers, and blood based tumour biomarkers for the detection of CRC and adenoma. Comprehensive up-to-date guidance is provided on indications, patient selection and strengths and limitations of each screening tool. Future research to inform clinical applications are discussed alongside objective measurement of research priorities. This joint APAGE-APSDE practice guideline is intended to provide an up-to-date guide to assist clinicians worldwide in utilising non-invasive biomarkers for CRC screening; it has particular salience for clinicians in the Asia-Pacific region.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Chan FKL, Wong MCS, Chan AT, et al. Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia. Gut. 2023. PMID: 37019620. doi:10.1136/gutjnl-2023-329429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。